Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PMV Pharmaceuticals Inc (PMVP)

  • SEC News
  • Oct. 27, 2025, 21:12 UTC
  • 0
  • 0 comments

New Form SCHEDULE 13D/A - PMV Pharmaceuticals, Inc. Filed: 2025-10-27 AccNo: 0000947871-25-000926 Size: 24 KB

Comment Full text

National Research (NRC)

  • SEC News
  • Oct. 27, 2025, 21:03 UTC
  • 0
  • 1 comments

(30% Negative) National Research Corporation (NRC) Reports Q4 2025 Financial Results

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Oct. 27, 2025, 21:00 UTC
  • 0
  • 1 comments

📋 MPM Asset Management Investors BV2014 LLC (Shareholder) plans to sell 4K shares of Werewolf Therapeutics, Inc. (at $1.77 each, total $8K) Filed: Oct 27, 2025 | ID: 046476

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Oct. 27, 2025, 20:59 UTC
  • 0
  • 1 comments

📋 MPM BioVentures 2014 (B), L.P. (Shareholder) plans to sell 9K shares of Werewolf Therapeutics, Inc. (at $1.77 each, total $15K) Filed: Oct 27, 2025 | ID: 046475

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Oct. 27, 2025, 20:59 UTC
  • 0
  • 1 comments

📋 MPM Asset Management LLC (Shareholder) plans to sell 21K shares of Werewolf Therapeutics, Inc. (at $1.77 each, total $36K) Filed: Oct 27, 2025 | ID: 046473

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Oct. 27, 2025, 20:59 UTC
  • 0
  • 1 comments

📋 UBS Oncology Impact Fund, L.P. (Shareholder) plans to sell 107K shares of Werewolf Therapeutics, Inc. (at $1.77 each, total $190K) Filed: Oct 27, 2025 | ID: 046471

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Oct. 27, 2025, 20:58 UTC
  • 0
  • 1 comments

📋 MPM Oncology Innovations Fund, L.P. (Shareholder) plans to sell 29K shares of Werewolf Therapeutics, Inc. (at $1.77 each, total $51K) Filed: Oct 27, 2025 | ID: 046470

Comment Full text

Werewolf Therapeutics Inc (HOWL)

  • SEC News
  • Oct. 27, 2025, 20:58 UTC
  • 0
  • 1 comments

📋 MPM BioVentures 2014, L.P. (Shareholder) plans to sell 130K shares of Werewolf Therapeutics, Inc. (at $1.77 each, total $230K) Filed: Oct 27, 2025 | ID: 046469

Comment Full text

Avidity Biosciences Inc (RNA)

  • SEC News
  • Oct. 27, 2025, 20:58 UTC
  • 0
  • 0 comments

New Form DEFA14A - Avidity Biosciences, Inc. Filed: 2025-10-27 AccNo: 0001193125-25-251732 Size: 56 KB

Comment Full text

Incannex Healthcare Ltd (IXHL)

  • SEC News
  • Oct. 27, 2025, 20:55 UTC
  • 0
  • 0 comments

New Form ARS - Incannex Healthcare Inc. Filed: 2025-10-27 AccNo: 0001213900-25-102657 Size: 1 MB

Comment Full text
  • Previous
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next

Search

News categories

  • Technical Exchange News(10277)
  • Event(1436)
  • SEC News(174426)
  • FDA Approval(9627)
  • Company Report(721)
  • Business News(117131)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin